Suppr超能文献

正骨科生物制剂在跟腱病中的应用:综述

Application of Orthobiologics in Achilles Tendinopathy: A Review.

作者信息

Ramires Luciano C, Jeyaraman Madhan, Muthu Sathish, Shankar A Navaladi, Santos Gabriel Silva, da Fonseca Lucas Furtado, Lana José Fábio, Rajendran Ramya Lakshmi, Gangadaran Prakash, Jogalekar Manasi P, Cardoso Alfredo A, Eickhoff Alex

机构信息

Department of Orthopaedics and Sports Medicine, Centro Clínico Mãe de Deus, Porto Alegre 90110-270, Brazil.

Department of Orthopaedics, Faculty of Medicine-Sri Lalithambigai Medical College and Hospital, Dr MGR Educational and Research Institute, Chennai 600095, India.

出版信息

Life (Basel). 2022 Mar 9;12(3):399. doi: 10.3390/life12030399.

Abstract

Orthobiologics are biological materials that are intended for the regeneration of bone, cartilage, and soft tissues. In this review, we discuss the application of orthobiologics in Achilles tendinopathy, more specifically. We explain the concepts and definitions of each orthobiologic and the literature regarding its use in tendon disorders. The biological potential of these materials can be harnessed and administered into injured tissues, particularly in areas where standard healing is disrupted, a typical feature of Achilles tendinopathy. These products contain a wide variety of cell populations, cytokines, and growth factors, which have been shown to modulate many other cells at local and distal sites in the body. Collectively, they can shift the state of escalated inflammation and degeneration to reestablish tissue homeostasis. The typical features of Achilles tendinopathy are failed healing responses, persistent inflammation, and predominant catabolic reactions. Therefore, the application of orthobiologic tools represents a viable solution, considering their demonstrated efficacy, safety, and relatively easy manipulation. Perhaps a synergistic approach regarding the combination of these orthobiologics may promote more significant clinical outcomes rather than individual application. Although numerous optimistic results have been registered in the literature, additional studies and clinical trials are still highly desired to further illuminate the clinical utility and efficacy of these therapeutic strategies in the management of tendinopathies.

摘要

矫形生物制品是用于骨、软骨和软组织再生的生物材料。在本综述中,我们将更具体地讨论矫形生物制品在跟腱病中的应用。我们解释了每种矫形生物制品的概念和定义,以及有关其在肌腱疾病中应用的文献。这些材料的生物潜能可被利用并应用于受损组织,特别是在标准愈合过程受到干扰的区域,这是跟腱病的一个典型特征。这些产品包含多种细胞群、细胞因子和生长因子,已证明它们可调节体内局部和远端部位的许多其他细胞。总体而言,它们可以改变炎症升级和退化的状态,以重建组织内稳态。跟腱病的典型特征是愈合反应失败、持续炎症和主要的分解代谢反应。因此,考虑到矫形生物制品已证明的疗效、安全性和相对容易操作,其应用是一种可行的解决方案。或许,这些矫形生物制品联合使用的协同方法可能比单独应用能带来更显著的临床效果。尽管文献中已有许多乐观的结果,但仍非常需要更多的研究和临床试验,以进一步阐明这些治疗策略在肌腱病管理中的临床效用和疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76fb/8954398/5abb59361b35/life-12-00399-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验